Catalent(CTLT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CTLT Catalent

盘前交易 07-22 05:19:34 EDT

57.91

-0.08

-0.14%

最高58.12	最低57.84	成交量93.98万
今开58.00	昨收57.99	日振幅0.48%
总市值104.81亿	流通市值104.19亿	总股本1.81亿
成交额5,445万	换手率0.52%	流通股本1.80亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CTLT","market":"US","secType":"STK","nameCN":"Catalent","latestPrice":57.91,"timestamp":1721419200000,"preClose":57.99,"halted":0,"volume":939764,"delay":0,"floatShares":179924320,"shares":180979849,"eps":-6.470426,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.08,"latestTime":"07-22 05:19:34 EDT","open":58,"high":58.115,"low":57.835,"amount":54448704.4668,"amplitude":0.004828,"askPrice":60,"askSize":1,"bidPrice":57,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-6.470426,"exchange":"NYSE","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721655000000},"adr":0,"listingDate":1406779200000,"adjPreClose":57.91,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":57.91,"preClose":57.91,"latestTime":"16:03 EDT","volume":16095,"amount":932070.45,"timestamp":1721419434342},"volumeRatio":0.5592607620496067,"impliedVol":0.1547,"impliedVolPercentile":0.088},"requestUrl":"/m/hq/s/CTLT","defaultTab":"news","newsList":[{"id":"2447263852","title":"巴克莱：维持Catalent(CTLT.US)评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2447263852","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2447263852?lang=zh_cn&edition=full","pubTime":"2024-06-29 00:20","pubTimestamp":1719591624,"startTime":"0","endTime":"0","summary":"巴克莱：维持catalent(CTLT.US)评级，由持股观望调整至持股观望评级,目标价由47.00美元调整至63.00美元。Catalent(CTLT.US)公司简介：康泰伦特是一个合同开发和制造组织，简称CDMO。它的业务分为四个部分:生物制品；软凝胶和口腔技术；口腔和专业交付以及临床供应服务。其收入主要来自与制药客户的长期供应协议。该公司在产品的整个生命周期(从药物开发过程到商业供应)为药物、基于蛋白质的生物制剂、细胞和基因疗法以及消费者健康产品提供一系列的开发和制造解决方案，在四大洲拥有50多家工厂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062900253595e47a25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062900253595e47a25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTLT"],"gpt_icon":0},{"id":"2446582501","title":"美国研究综述-Alphabet、Equity Residential、Infinera","url":"https://stock-news.laohu8.com/highlight/detail?id=2446582501","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446582501?lang=zh_cn&edition=full","pubTime":"2024-06-28 20:16","pubTimestamp":1719577011,"startTime":"0","endTime":"0","summary":"    路透6月28日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Alphabet、Equity Residential 和 Infinera。要闻 * Alphabet Inc   ：罗森布拉特证券公司将其评级从 \"买入 \"下调至 \"中性\"。* Cincinnati Financial Corp   ：花旗集团将其评级从 \"买入 \"上调至 \"买入 * Equity Residential   ：Piper Sandler将其评级从中性上调至增持 * 英飞朗  ：Stifel将其评级从 \"买入 \"下调至 \"持有 以下是路透周五报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTLT","EQH","GOOGL","LU1280957306.USD","LU0106831901.USD","DE","APOG","CHWY","CHPT","CRL","CRBG","CRK","LU2264538146.SGD","AFG","AR","LU0494093205.USD","CMG","IE00BJTD4N35.SGD","AMP","LU0708995401.HKD","AOSL","CERT","DAL","ARRY","DAY","LU0128525929.USD","T","CINF","BKR","DCTH","AFL","ELAN","LU0109391861.USD","DLR","BWIN","ALSN","BL","CHK","AVTR","AGCO","TXG","BHF","DLTR","LU0061475181.USD","BB","ACCD","CALC","BP"],"gpt_icon":0},{"id":"2446007600","title":"韦格威生产商诺和诺德将斥资 41 亿美元加强美国生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2446007600","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446007600?lang=zh_cn&edition=full","pubTime":"2024-06-25 02:15","pubTimestamp":1719252906,"startTime":"0","endTime":"0","summary":" Isabelle Yr Carlsson/Maggie Fick    路透6月24日 - 肥胖症药物生产商诺和诺德  周一表示，将斥资41亿美元在美国建造一座工厂，为其广受欢迎的减肥药Wegovy和糖尿病药物Ozempic灌装注射剂。诺和诺德公司于 31 年前开设了这家工厂。为了提高诺和诺德的Wegovy生产能力，诺和诺德的控股股东诺和诺德控股公司于今年2月宣布，将以165亿美元的价格收购美国大型合同药品生产商康泰伦特公司，后者是Wegovy的分包商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4007","BK4530","BK4588","BK4585","CTLT","NVO","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2445765135","title":"BUZZ-Sarepta 公司的杜兴氏基因疗法获 FDA 批准扩大使用范围，公司业绩大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2445765135","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445765135?lang=zh_cn&edition=full","pubTime":"2024-06-21 22:36","pubTimestamp":1718980589,"startTime":"0","endTime":"0","summary":"    6月21日 - ** Sarepta Therapeutics   的股价在早盘交易中大涨约33%，创下三年多来的新高 ** 按目前水平计算，公司市值将增加近 40 亿美元 ** 周四晚些时候，美国食品和药物管理局批准  公司的基因疗法 Elevidys 用于遗传性进行性肌肉萎缩症患者的治疗。** 包括本交易日的涨幅在内，该公司股价今年累计上涨超过68%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","BK4566","LU1854104046.USD","LU2125909759.SGD","LU0882574055.USD","CTLT","IE0009355771.USD","BK4585","LU0011850046.USD","LU0640476718.USD","BK4588","LU1720051017.SGD","LU1720051108.HKD","LU1854103824.USD","LU1923622291.USD","TMO","LU2041044095.USD","IE00BJJMRZ35.SGD","LU0528227936.USD","LU1791710400.SGD","LU1670628061.USD","SRPT","BK4530","LU0122379950.USD","LU0114720955.EUR","LU2063271972.USD","LU1989771016.USD","LU1791710582.SGD","LU1670627923.USD","BK4535","BK4007","BK4139","IE00BFTCPJ56.SGD","BK4581","LU2125909247.SGD","IE0002141913.USD","LU2125909916.SGD","LU1712237335.SGD","BUZZ","BK4121","IE0034235188.USD","LU1064131342.USD","GB00BDT5M118.USD","LU1623119135.USD","LU1280957306.USD","LU0957791311.USD","LU2357305700.SGD","LU1923622614.USD","LU2264538146.SGD","LU0557290698.USD"],"gpt_icon":0},{"id":"2439015524","title":"康泰伦特股东批准与诺和控股的交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2439015524","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439015524?lang=zh_cn&edition=full","pubTime":"2024-05-29 21:14","pubTimestamp":1716988484,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透5月29日 - 康泰伦特  周三称，其股东已投票通过了与诺和诺德  母公司诺和诺德控股（Novo Holdings）的交易。今年2月，Novo Holdings同意以165亿美元收购康泰伦特。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4588","BK4532","CTLT","BK4585","NVO","BK4530"],"gpt_icon":0},{"id":"2425519231","title":"媒体-Ares 和 Blue Owl 牵头为康泰伦特交易提供 48 亿美元私人债务 - 彭博新闻社","url":"https://stock-news.laohu8.com/highlight/detail?id=2425519231","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2425519231?lang=zh_cn&edition=full","pubTime":"2024-04-06 04:47","pubTimestamp":1712350052,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    4月5日 - -- 来源链接：  -- 注：路透社未核实此报道，不保证其准确性","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4007","CTLT","BK4530","AACT.U"],"gpt_icon":0},{"id":"2417795077","title":"首席财务官表示，如果康泰伦特交易未完成，诺和诺德将提高资本支出","url":"https://stock-news.laohu8.com/highlight/detail?id=2417795077","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417795077?lang=zh_cn&edition=full","pubTime":"2024-03-07 23:53","pubTimestamp":1709826819,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透社哥本哈根3月7日 - 丹麦制药公司诺和诺德  首席财务官卡斯滕-蒙克-克努森（Karsten Munk Knudsen）周四表示，如果公司不能完成计划中的康泰伦特  收购案，诺和诺德将增加资本支出，建设灌装-成品生产能力。Knudsen在诺和诺德的资本市场日上对分析师说，如果诺和诺德没有完成对康泰伦特的收购，诺和诺德还将与合同药品生产商进行更多的交易。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4530","BK4007","NVO","BK4585","CTLT","BK4588","BK4532"],"gpt_icon":0},{"id":"2416114168","title":"BUZZ-DNB 因收购 \"改变游戏规则 \"的康泰伦特而上调诺和诺德评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2416114168","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2416114168?lang=zh_cn&edition=full","pubTime":"2024-03-04 20:06","pubTimestamp":1709553972,"startTime":"0","endTime":"0","summary":"    3月4日 - ** DNB Markets将诺和诺德  的评级从 \"持有 \"上调至 \"买入\"，称其收购 ，主要生产分包商康泰伦特  将 \"改变游戏规则\"，从2026年起，Wegovy的销售将由 \"需求驱动\"。** DNB表示，Wegovy的供应瓶颈在于灌装链，收购康泰伦特的三个灌装-成品生产基地有可能解决Wegovy的供应问题，并支持进一步的推广。** DNB 认为 Wegovy 的销量在 2026 年后将大幅增长，并预计在没有供应限制的情况下将会快速推广和吸收。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTLT","NVO","DNB","LLY","BUZZ"],"gpt_icon":0},{"id":"2411534424","title":"韦格威包装供应商康泰伦特裁员 300 人","url":"https://stock-news.laohu8.com/highlight/detail?id=2411534424","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411534424?lang=zh_cn&edition=full","pubTime":"2024-02-15 05:32","pubTimestamp":1707946350,"startTime":"0","endTime":"0","summary":"    路透社2月14日 - 康泰伦特  在周三提交的一份监管文件中披露，作为其正在进行的重组计划的一部分，该公司已经裁减了约300名员工。康泰伦特表示，裁员产生了约 1200 万美元的相关费用。在同意诺和诺德母公司  提出的165亿美元收购要约几天后，康泰伦特上周的第二季度收入超过了华尔街的预期。康泰伦特的客户还包括诺和诺德的竞争对手礼来  、Sarepta Therapeutics   和阿斯利康  。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4007","CTLT","BK4530"],"gpt_icon":0},{"id":"2410529820","title":"更新版 1-更新 2-康泰伦特销售额超预期，焦点转向诺和诺德交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2410529820","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2410529820?lang=zh_cn&edition=full","pubTime":"2024-02-09 23:50","pubTimestamp":1707493806,"startTime":"0","endTime":"0","summary":"     路透2月9日 - 合同药品生产商康泰伦特  周五的第二季度收入超过了华尔街的预期，几天前它同意了诺和诺德  母公司提出的165亿美元的收购要约。康泰伦特的股价小幅上涨，报 56.70 美元，而诺和诺德的报价为每股 63.50 美元。交易完成后，诺和诺德控股公司将以 110 亿美元的价格把康泰伦特在意大利阿纳尼、比利时布鲁塞尔和印第安纳州布卢明顿的主要灌装工厂出售给诺和诺德。由于一家工厂发生火灾，康泰伦特一次性支出了 900 万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237438978.USD","LU1280957306.USD","LU2491050154.USD","LU0640476718.USD","LU0456855351.SGD","IE00B2B36J28.USD","SRPT","BK4533","SG9999014898.SGD","IE00BJJMRZ35.SGD","LU1814569148.SGD","LU2264538146.SGD","LU0320765059.SGD","BK4139","LU0466842654.USD","SG9999001176.USD","BK4534","IE0002141913.USD","LU0109391861.USD","SG9999014880.SGD","LU0114720955.EUR","BK4588","LLY","LU2491050071.SGD","LU0058720904.USD","LU0198837287.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU0256863811.USD","LU1267930730.SGD","LU0417517546.SGD","LU2468319806.SGD","LU1712237335.SGD","BK4530","LU1057294990.SGD","BK4585","CTLT","LU0097036916.USD","NVO","LU1064131342.USD","LU0689472784.USD","BK4532","LU2237443549.SGD","LU1023059063.AUD","SG9999001176.SGD","LU0708995401.HKD","LU0882574055.USD","SG9999013999.USD","LU1623119135.USD","LU2237443978.SGD"],"gpt_icon":0},{"id":"2410055786","title":"更新 2-康泰伦特第二季度销售额超预期，因诺和诺德控股公司（Novo Holdings）将其收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2410055786","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2410055786?lang=zh_cn&edition=full","pubTime":"2024-02-09 22:13","pubTimestamp":1707488006,"startTime":"0","endTime":"0","summary":"     路透2月9日 - 康泰伦特  周五公布的第二季度 收入略高于华尔街预期，几天前这家合同药品生产商同意了诺和诺德  母公司165亿美元的收购要约。诺和诺德控股公司的收购是在康泰伦特公司 8 月份与激进投资者埃利奥特投资管理公司达成和解后进行的战略审查之后进行的。根据 LSEG 的数据，康泰伦特第二季度的收入为 10.3 亿美元，高于分析师预计的 10.1 亿美元。康泰伦特表示，本季度将不召开财报后电话会议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001176.SGD","LU0058720904.USD","SG9999014898.SGD","IE00BFTCPJ56.SGD","LU1814569148.SGD","LU1023059063.AUD","BK4532","LU0689472784.USD","LU0109391861.USD","LU0820561909.HKD","LU2602419157.SGD","BK4534","LU0122379950.USD","SG9999013999.USD","IE0009355771.USD","LU0456855351.SGD","LU1057294990.SGD","IE00B2B36J28.USD","LU2264538146.SGD","SG9999014880.SGD","LU2468319806.SGD","NVO","LU1988902786.USD","LU1280957306.USD","LU2237438978.USD","GB00BDT5M118.USD","LLY","LU0882574055.USD","LU0708995401.HKD","LU0320765059.SGD","BK4533","BK4530","LU0256863811.USD","LU0672654240.SGD","IE00BJJMRZ35.SGD","LU0466842654.USD","LU1551013425.SGD","LU0198837287.USD","BK4007","LU0417517546.SGD","BK4585","LU0061475181.USD","LU1267930730.SGD","SG9999001176.USD","LU0289739699.SGD","LU1064131342.USD","LU0640476718.USD","IE00BJT1NW94.SGD","LU0820561818.USD","CTLT"],"gpt_icon":0},{"id":"2410058591","title":"更新版 1-诺和诺德控股收购康泰伦特，季度销售额超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2410058591","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2410058591?lang=zh_cn&edition=full","pubTime":"2024-02-09 21:14","pubTimestamp":1707484474,"startTime":"0","endTime":"0","summary":"根据 LSEG 的数据，康泰伦特第二季度的收入为 10.3 亿美元，高于分析师预计的 10.1 亿美元。康泰伦特是诺和诺德流行的减肥药 Wegovy 的主要供应商，负责无菌条件下注射器和注射笔的灌装和包装。交易完成后，诺和诺德母公司诺和控股将以 110 亿美元的价格把康泰伦特在意大利阿纳尼、比利时布鲁塞尔和印第安纳州布鲁明顿的三个关键灌装-成品基地出售给诺和诺德。康泰伦特本季度每股净亏损 1.12 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4530","BK4588","BK4532","CTLT","BK4007","NVO","BK4585"],"gpt_icon":0},{"id":"2410103010","title":"康泰伦特第二季度营收略高于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2410103010","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2410103010?lang=zh_cn&edition=full","pubTime":"2024-02-09 21:03","pubTimestamp":1707483783,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透2月9日 - 康泰伦特  周五公布的季度收入略高于华尔街预期，几天前这家合同药品生产商 同意了诺和诺德  母公司165亿美元的收购要约。 根据伦敦证券交易所集团（LSEG）的数据，康泰伦特第二季度的营收为10.3亿美元，高于分析师预计的10.1亿美元，这主要得益于康泰伦特主要工厂生产的改善。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTLT"],"gpt_icon":0},{"id":"2410725200","title":"未来一天的看点--2 月 9 日星期五","url":"https://stock-news.laohu8.com/highlight/detail?id=2410725200","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2410725200?lang=zh_cn&edition=full","pubTime":"2024-02-09 03:30","pubTimestamp":1707420609,"startTime":"0","endTime":"0","summary":" (The Day Ahead 是一份电子邮件和 PDF 格式的出版物，内容包括当天的主要新闻和事件、分析和其他专题。要接收《The Day Ahead》，Eikon 用户可在    注册。1 月份的失业率可能从前一个月的 5.8% 上升至 5.9%。墨西哥国家统计局将公布 12 月份工业产值可能下降 0.1%，而 11 月份为下降 1.0%。另外，巴西统计局 IBGE 预计将公布 12 月份服务业可能增长 0.7%，上月为增长 0.4%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","BK4534","BK4581","BK4588","LU0234572021.USD","BK4007","CTLT","LU1244550221.USD","BK4550","BK4177","BK4585","LU1244550577.SGD","BK4530","PEP","BK4504","BK4533","LU1244550494.USD"],"gpt_icon":0},{"id":"2409791898","title":"阿斯利康称康泰伦特交易显示了内部能力的重要性","url":"https://stock-news.laohu8.com/highlight/detail?id=2409791898","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2409791898?lang=zh_cn&edition=full","pubTime":"2024-02-08 18:42","pubTimestamp":1707388962,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透伦敦2月8日 - 阿斯利康  周四表示，本周合同药品制造商康泰伦特  出售给诺和诺德  母公司的交易表明了建立独立供应链的重要性。阿斯利康首席执行官帕斯卡尔-索里奥（Pascal Soriot）在发布第四季度财报后告诉记者，阿斯利康是康泰伦特的客户，为其生产部分药品，但阿斯利康正在努力提高内部产能，以减少对合同制药商的依赖。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","BK4530","LU1829250122.USD","BK4568","LU0109394709.USD","BK4007","CTLT","BK4585","LU0320765992.SGD","LU2236285917.USD","BK4588","LU0889565916.HKD"],"gpt_icon":0},{"id":"2409773702","title":"更新版 1-欧盟监察机构正在调查康泰伦特生产基地出售给诺和诺德的药物的供应情况","url":"https://stock-news.laohu8.com/highlight/detail?id=2409773702","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2409773702?lang=zh_cn&edition=full","pubTime":"2024-02-08 01:23","pubTimestamp":1707326603,"startTime":"0","endTime":"0","summary":"  Ludwig Burger    路透法兰克福2月7日 - 欧盟药品监管机构周三表示，将调查康泰伦特  生产基地加工并出售给诺和诺德  的药品的供应风险，这是该机构防止药品短缺任务的一部分。该交易还包括以 110 亿美元的价格将康泰伦特位于意大利阿纳尼、比利时布鲁塞尔和印第安纳州布卢明顿的三个灌装工厂出售给诺和诺德。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0672654240.SGD","LU2237443549.SGD","LU1551013342.USD","LU0417517546.SGD","LU1988902786.USD","SG9999001176.USD","LU2264538146.SGD","SG9999001176.SGD","BK4533","LU0114720955.EUR","LU2237443382.USD","LU0097036916.USD","LU0943347566.SGD","SG9999013999.USD","LU2237443622.USD","LU2491050071.SGD","LU2237438978.USD","LU2491049909.HKD","BK4588","BK4534","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0058720904.USD","LU0289739699.SGD","LU1057294990.SGD","LU1814569148.SGD","LU1551013425.SGD","LU2468319806.SGD","LU1280957306.USD","LU1023059063.AUD","LU2237443978.SGD","LU0882574055.USD","GB00BDT5M118.USD","BK4532","LLY","IE0002141913.USD","BK4581","LU0109391861.USD","LU0122379950.USD","LU0708995401.HKD","LU0820561909.HKD","LU2491050154.USD","BK4007","CTLT","SG9999014906.USD","SG9999014914.USD","LU0061475181.USD","LU0256863811.USD","NVO","SG9999014880.SGD"],"gpt_icon":0},{"id":"2409622177","title":"康泰伦特公司  预计每股亏损2美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2409622177","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2409622177?lang=zh_cn&edition=full","pubTime":"2024-02-07 21:56","pubTimestamp":1707314169,"startTime":"0","endTime":"0","summary":"   * 康泰伦特公司   将于2月9日公布截至2023年12月31日的财报，预计该公司的季度收入将出现下降。* LSEG 分析师对康泰伦特公司的平均预期是每股亏损 2 美分。* 华尔街对康泰伦特公司 12 个月目标价的中位数为 63.50 美元，高于上一交易日的收盘价 58.46 美元。2月7日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTLT"],"gpt_icon":0},{"id":"2409232295","title":"美国 FDA 发现将出售给诺和诺德的康泰伦特工厂存在控制漏洞","url":"https://stock-news.laohu8.com/highlight/detail?id=2409232295","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2409232295?lang=zh_cn&edition=full","pubTime":"2024-02-07 06:15","pubTimestamp":1707257736,"startTime":"0","endTime":"0","summary":"美国食品和药物管理局于 10 月 31 日至 11 月 15 日对该工厂进行了检查，发现了五条不同的意见，其中包括康泰伦特未能彻底审查某些批次产品中存在的无法解释的差异。康泰伦特和诺和诺德没有立即回应置评请求。根据 FDA 的工厂检查数据库，康泰伦特将有机会主动解决报告中指出的问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0708995401.HKD","SG9999013999.USD","BK4581","IE00BJT1NW94.SGD","SG9999001176.USD","LU0097036916.USD","LU0820561818.USD","LU1023059063.AUD","LU2237443622.USD","NVO","LU2237438978.USD","LLY","SG9999014914.USD","BK4585","LU0456855351.SGD","BK4007","BK4530","LU1988902786.USD","LU1712237335.SGD","LU2602419157.SGD","SG9999014898.SGD","LU0943347566.SGD","IE0009355771.USD","LU1623119135.USD","BK4588","LU0640476718.USD","LU0672654240.SGD","LU0109391861.USD","IE00BFTCPJ56.SGD","LU0289739699.SGD","IE00B2B36J28.USD","LU2237443978.SGD","CTLT","LU0198837287.USD","LU0114720955.EUR","LU0058720904.USD","LU1280957306.USD","LU0320765059.SGD","LU1814569148.SGD","LU0061475181.USD","LU0466842654.USD","LU2237443549.SGD","LU0820561909.HKD","LU0689472784.USD","LU1267930730.SGD","LU0417517546.SGD","LU1057294990.SGD","LU2468319806.SGD","LU1064131342.USD","LU2237443382.USD"],"gpt_icon":0},{"id":"2409233980","title":"媒体-Wegovy 生产商康泰伦特印第安纳州工厂不符合安全和质量标准 - 彭博新闻社","url":"https://stock-news.laohu8.com/highlight/detail?id=2409233980","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2409233980?lang=zh_cn&edition=full","pubTime":"2024-02-07 04:02","pubTimestamp":1707249741,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    2月6日 - -- 来源链接：  -- 注：路透未核实此报道，不保证其准确性","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTLT","BK4007","BK4585","BK4588","BK4530"],"gpt_icon":0},{"id":"2409284786","title":"更新 7-礼来顺应减肥药需求浪潮，努力扩大产能","url":"https://stock-news.laohu8.com/highlight/detail?id=2409284786","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2409284786?lang=zh_cn&edition=full","pubTime":"2024-02-07 02:17","pubTimestamp":1707243432,"startTime":"0","endTime":"0","summary":"  Patrick  Wingrove/Bhanvi Satija    路透2月6日 - 礼来  周二预测，由于最近获批的减肥药Zepbound需求激增，2024年的利润将高于华尔街预期，并表示最快将在今年通过扩大产能获得新的供应。礼来公司表示，预计 2024 年下半年生产的可销售剂量将是去年下半年的 1.5 倍。这家总部位于印第安纳波利斯的制药商表示，虽然它将扩大生产能力，但预计2024年Mounjaro和Zepbound的需求量将超过供应量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014914.USD","LU0640476718.USD","LU0689472784.USD","BK4534","LU0456855351.SGD","IE0002141913.USD","LU0820561818.USD","BK4588","LU1551013342.USD","LU2491049909.HKD","SG9999014898.SGD","LU0097036916.USD","LU0320765059.SGD","LU2491050154.USD","LU0882574055.USD","LU1623119135.USD","LU1064131342.USD","GB00BDT5M118.USD","LU0820561909.HKD","LU2237443978.SGD","BK4581","LU2237438978.USD","LU2264538146.SGD","LLY","SG9999014906.USD","BK4530","LU1712237335.SGD","BK4533","BK4007","LU0943347566.SGD","LU2237443382.USD","CTLT","IE00BFTCPJ56.SGD","LU1551013425.SGD","IE0009355771.USD","IE00B2B36J28.USD","LU2602419157.SGD","LU0114720955.EUR","LU0256863811.USD","LU0417517546.SGD","SG9999014880.SGD","LU0466842654.USD","LU0198837287.USD","LU1267930730.SGD","LU2491050071.SGD","LU2237443622.USD","BK4585","LU2237443549.SGD","IE00BJJMRZ35.SGD","LU0672654240.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.catalent.com","stockEarnings":[{"period":"1week","weight":0.0057},{"period":"1month","weight":0.0516},{"period":"3month","weight":0.0438},{"period":"6month","weight":0.1768},{"period":"1year","weight":0.2171},{"period":"ytd","weight":0.2889}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Catalent, Inc.是全球领先的先进交付技术以及药物开发和制造解决方案的提供商。该公司的口服，注射，细胞和基因疗法以及细胞和呼吸道递送技术可满足制药行业的各种需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.058226},{"month":2,"riseRate":0.6,"avgChangeRate":0.038189},{"month":3,"riseRate":0.4,"avgChangeRate":0.009076},{"month":4,"riseRate":0.6,"avgChangeRate":0.013795},{"month":5,"riseRate":0.5,"avgChangeRate":0.014479},{"month":6,"riseRate":0.6,"avgChangeRate":0.020877},{"month":7,"riseRate":0.8,"avgChangeRate":0.080169},{"month":8,"riseRate":0.6,"avgChangeRate":0.00779},{"month":9,"riseRate":0.4,"avgChangeRate":-0.04074},{"month":10,"riseRate":0.6,"avgChangeRate":-0.028588},{"month":11,"riseRate":0.6,"avgChangeRate":0.01097},{"month":12,"riseRate":0.5,"avgChangeRate":0.002741}],"exchange":"NYSE","name":"Catalent","nameEN":"Catalent"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Catalent(CTLT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Catalent(CTLT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Catalent,CTLT,Catalent股票,Catalent股票老虎,Catalent股票老虎国际,Catalent行情,Catalent股票行情,Catalent股价,Catalent股市,Catalent股票价格,Catalent股票交易,Catalent股票购买,Catalent股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Catalent(CTLT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Catalent(CTLT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}